Issue 3/2014
Content (22 Articles)
Breast cancer risk accumulation starts early: prevention must also
Graham A. Colditz, Kari Bohlke, Catherine S. Berkey
The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines
Azadeh Motevalli, Hemad Yasaei, Sara Anjomani Virmouni, Predrag Slijepcevic, Terry Roberts
Suppression of triple-negative breast cancer metastasis by pan-DAC inhibitor panobinostat via inhibition of ZEB family of EMT master regulators
Lyndsay V. Rhodes, Chandra R. Tate, H. Chris Segar, Hope E. Burks, Theresa B. Phamduy, Van Hoang, Steven Elliott, Diari Gilliam, F. Nell Pounder, Muralidharan Anbalagan, Douglas B. Chrisey, Brian G. Rowan, Matthew E. Burow, Bridgette M. Collins-Burow
T helper responses are maintained by basal-like breast cancer cells and confer to immune modulation via upregulation of PD-1 ligands
Pinar Karasar, Gunes Esendagli
Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer
Hee Jin Lee, In Ah Park, So Yeon Park, An Na Seo, Bora Lim, Yun Chai, In Hye Song, Na Eun Kim, Joo Young Kim, Jong Han Yu, Jin-Hee Ahn, Gyungyub Gong
Assessment of individuals with BRCA1 and BRCA2 large rearrangements in high-risk breast and ovarian cancer families
Angela G. Arnold, Ebunoluwa Otegbeye, Megan Harlan Fleischut, Emily A. Glogowski, Beth Siegel, Sherry R. Boyar, Erin Salo-Mullen, Kim Amoroso, Margaret Sheehan, Janice L. Berliner, Zsofia K. Stadler, Noah D. Kauff, Kenneth Offit, Mark E. Robson, Liying Zhang
Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groups
Wai Jin Tan, Johnathan C. Lai, Aye Aye Thike, Jeffrey Chun Tatt Lim, Sie Yong Tan, Valerie Cui Yun Koh, Tse Hui Lim, Boon Huat Bay, Min-Han Tan, Puay Hoon Tan
Expression of membrane transporters and metabolic enzymes involved in estrone-3-sulphate disposition in human breast tumour tissues
Nilasha Banerjee, Naomi Miller, Christine Allen, Reina Bendayan
MRI breast screening in high-risk women: cancer detection and survival analysis
Evans D. Gareth, Kesavan Nisha, Lim Yit, Gadde Soujanye, Hurley Emma, Nathalie J. Massat, Anthony J. Maxwell, Ingham Sarah, Eeles Rosalind, Martin O. Leach, Howell Anthony, Duffy Stephen
Hereditary breast and ovarian cancer and reproduction: an observational study on the suitability of preimplantation genetic diagnosis for both asymptomatic carriers and breast cancer survivors
Inge A. P. Derks-Smeets, Christine E. M. de Die-Smulders, Shari Mackens, Ron van Golde, Aimee D. Paulussen, Jos Dreesen, Herman Tournaye, Pieter Verdyck, Vivianne C. G. Tjan-Heijnen, Madelon Meijer-Hoogeveen, Jacques De Greve, Joep Geraedts, Martine De Rycke, Maryse Bonduelle, Willem M. Verpoest
Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial
Melissa V. Hansen, Lærke T. Andersen, Michael T. Madsen, Ida Hageman, Lars S. Rasmussen, Susanne Bokmand, Jacob Rosenberg, Ismail Gögenur
Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms
C. A. Drukker, M. V. Nijenhuis, J. M. Bueno-de-Mesquita, V. P. Retèl, W. H. van Harten, H. van Tinteren, J. Wesseling, M. K. Schmidt, L. J. van’t Veer, G. S. Sonke, E. J. T. Rutgers, M. J. van de Vijver, S. C. Linn
Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing
Priyanka Sharma, Jennifer R. Klemp, Bruce F. Kimler, Jonathan D. Mahnken, Larry J. Geier, Qamar J. Khan, Manana Elia, Carol S. Connor, Marilee K. McGinness, Joshua M. W. Mammen, Jamie L. Wagner, Claire Ward, Lori Ranallo, Catherine J. Knight, Shane R. Stecklein, Roy A. Jensen, Carol J. Fabian, Andrew K. Godwin
Adolescent physical activity in relation to breast cancer risk
Caroline E. Boeke, A. Heather Eliassen, Hannah Oh, Donna Spiegelman, Walter C. Willett, Rulla M. Tamimi
Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer
Denise A. Yardley, Peter A. Kaufman, Adam Brufsky, Marianne Ulcickas Yood, Hope Rugo, Musa Mayer, Cheng Quah, Bongin Yoo, Debu Tripathy
Post-diagnosis physical activity and survival after breast cancer diagnosis: the Long Island Breast Cancer Study
Patrick T. Bradshaw, Joseph G. Ibrahim, Nikhil Khankari, Rebecca J. Cleveland, Page E. Abrahamson, June Stevens, Jessie A. Satia, Susan L. Teitelbaum, Alfred I. Neugut, Marilie D. Gammon
Racial disparities in initiation of adjuvant endocrine therapy of early breast cancer
Katherine E. Reeder-Hayes, Anne Marie Meyer, Stacie B. Dusetzina, Huan Liu, Stephanie B. Wheeler
Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010–2011)
Helmneh M. Sineshaw, Mia Gaudet, Elizabeth M. Ward, W. Dana Flanders, Carol Desantis, Chun Chieh Lin, Ahmedin Jemal
Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast
Nehmat Houssami, Linn A. Abraham, Tracy Onega, Laura C. Collins, Brian L. Sprague, Deirdre A. Hill, Diana L. Miglioretti
Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan
Muhammad U. Rashid, Noor Muhammad, Saima Faisal, Asim Amin, Ute Hamann
Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes
Chin-Hsiao Tseng
Microsatellite genotyping reveals a signature in breast cancer exomes
L. J. McIver, N. C. Fonville, E. Karunasena, H. R. Garner